Return to Answers From the Lab

Vector-Borne Diseases: Dr. Bobbi Pritt & Dr. Bill Morice

By Suzanne Ferguson • July 1, 2021
Related Episodes
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.

By Samantha Rossi • April 23, 2024
Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.

By Sarah Jarvis • April 18, 2024
Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.

By Samantha Rossi • April 16, 2024

Suzanne Ferguson

Suzanne Ferguson is a Marketing Channel Manager at Mayo Clinic Laboratories and has worked at Mayo Clinic since 2014. Outside of work, Suzanne can be found traveling, reading and spending time with her family.

Related Posts
Mayo Clinic Laboratory and Pathology Research Roundup: April 23
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.
The Expanding Reach of the Laboratory Outreach Program